miR‑92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2

Fei Liu(Cangzhou Central Hospital), Cuizhi Geng(Hebei Medical University)
International Journal of Oncology
July 18, 2018
10.3892/ijo.2018.4486
Cited by 41

Related Papers

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
|The Journal of Cell Biology|2010|811
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
|BMJ|2023|82
Increased expression of monoamine oxidase A is associated with epithelial to mesenchymal transition and clinicopathological features in non-small cell lung cancer
|Oncology Letters|2017|58